| Ticker: | PRHSX |
| Manager: | Kris H. Jenner |
| Manager Since: | 01/00 |
| NAV (05/21/2013): | 50.37 |
| Objective: | Equity - Sector Health |
| Peer: | HL MG |
| Net Assets ($mil): | 5016.00 |
| Inception: | 12/29/1995 |
PRHSX : Description
The fund was incepted in December 1995 and is managed by T.Rowe Price Associates. This health fund's main objective is long-term capital appreciation. The fund invests at least 80% of its net assets in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. The fund may invest in companies of any size, the majority of fund assets are invested in large and mid capitalization companies. Dividends and capital gains, if any, are declared annually in December.
PRHSX : Composition - 05/13
| Stocks | 98.86% |
| Foreign Stocks | 12.16% |
| Cash | 2.04% |
| Bonds | 0.00% |
| Foreign Bonds | 0.00% |
| Preferred | 0.13% |
| Convertible | 0.19% |
| Other | -1.22% |
| Foreign Hedged | 0.00% |
PRHSX : Style Analysis - 05/13
| Large Growth | 41.90% |
| Large Value | 0.00% |
| Small Growth | 0.00% |
| Small Value | 0.00% |
| Foreign Stock | 41.90% |
| Emerging Market | 0.00% |
| Precious Metals | 0.00% |
| Intermediate Bond | 0.00% |
| High Yield Bond | 30.58% |
| Foreign Bond | 0.00% |
PRHSX : Risk Analysis
| Beta v. S&P 500 | 0.97 |
| Beta v. EAFE | -0.04 |
| Beta v. Barclays Agg Bond | -0.22 |
| Alpha 3 Yr | 10.56 |
| Alpha 5 Yr | 11.06 |
| R-Sq 3 Yr | 0.76 |
| R-Sq 5 Yr | 0.71 |
| Std Dev 3 Yr | 16.20 |
| Std Dev 5 Yr | 19.25 |
| Sharpe 3 Yr | 1.53 |
| Sharpe 5 Yr | 0.91 |
PRHSX : Fees
| Expense Ratio | 0.79 |
| % Max Load | NA |
| % Min Load | NA |
| % Deferred Load | NA |
| % Redemption | NA |
| % Max 12 B1 Fee | 0.00 |
| % Max Mgt Fee | 0.65 |
PRHSX : Purchase Choices:
| Min Initial Investment | 2500 |
| Min Subsequent Investment | 100 |
PRHSX : Returns Analysis - Annual
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | YTD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAV ($) | 19.95 | 23.11 | 25.07 | 26.13 | 28.32 | 19.80 | 26.17 | 30.28 | 32.60 | 41.22 | 50.37 |
| Total Return (%) | 37.49 | 15.84 | 13.53 | 9.57 | 18.74 | -28.77 | 32.17 | 16.32 | 11.00 | 31.93 | 18.80 |
| Annual Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.26 |
| Relative Performance | |||||||||||
| Rel Performance-S&P500(%) | 88.00 | 49.67 | 86.42 | -62.17 | 132.52 | 82.37 | 57.51 | 12.62 | 89.07 | 159.41 | 60.59 |
| Rel Performance-Obj.Ret.(%) | 69.46 | 70.60 | 45.70 | 58.44 | 98.82 | -50.74 | 102.95 | 83.01 | 32.58 | 127.02 | -7.80 |
| Ret.Quintile vs Obj(1 is best) | 2 | 1 | 2 | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 3 |
| Turnover, Yields, and Gains | |||||||||||
| Fund Assets Net($mil) | 1,027 | 1,329 | 1,342 | 1,714 | 2,295 | 1,700 | 2,157 | 2,483 | 3,073 | 5,016 | 5,016 |
| Annual Turnover (%) | 45.00 | 44.10 | 55.70 | 48.80 | 44.80 | 47.40 | 33.40 | 36.40 | 23.30 | 12.90 | 0.00 |
| Annual Dividend Paid ($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.00 |
| Annual Capital Gains Paid($) | 0.00 | 0.00 | 1.16 | 1.34 | 2.68 | 0.34 | 0.00 | 0.16 | 0.96 | 1.67 | 0.00 |
PRHSX : Returns Analysis - Trailing Total Return
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | 15 Year | 20 Year | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Return (through 05/13) | 3.20% | 10.29% | 22.77% | 18.80% | 30.82% | 23.46% | 15.64% | 15.16% | 11.89% | NA |
| Ret. Percentile vs. Obj. (1 is best) | 62 | 68 | 36 | 58 | 19 | 14 | 17 | 9 | 2 | NA |
PRHSX : Stock Portfolio Snapshot - 05/13
| Average Price/Earnings | 26.91 |
| Average Price/Book | 4.86 |
| Average EPS Growth | 14.88 |
| Average Market Value | 19,453.00 |
PRHSX : Stock Sector Breakout - 05/13
PRHSX : Top Holdings - 05/13
| Name | Weight | Shares |
|---|---|---|
| ALEXION PHARMACEUTICALS INC | 6.17 | 3,298,000 |
| CATAMARAN CORP | 4.63 | 4,925,000 |
| GILEAD SCIENCES INC | 4.10 | 2,800,000 |
| VALEANT PHARMACEUTICALS | 2.92 | 2,450,000 |
| MCKESSON CORP | 1.70 | 877,400 |
| REGENERON PHARMACEUTICALS | 2.18 | 639,900 |
| UNITEDHEALTH GROUP INC | 2.16 | 2,000,000 |
| INCYTE PHARMACEUTICALS INC | 1.75 | 5,290,000 |
| PHARMACYCLICS INC | 2.48 | 2,150,000 |